LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $203,000 | -45.1% | 1,612 | -28.1% | 0.00% | -50.0% |
| Q1 2018 | $370,000 | +28.9% | 2,242 | +7.1% | 0.00% | 0.0% |
| Q4 2017 | $287,000 | -20.1% | 2,093 | -20.6% | 0.00% | 0.0% |
| Q3 2017 | $359,000 | +6.2% | 2,637 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $338,000 | +19.9% | 2,780 | +4.5% | 0.00% | 0.0% |
| Q1 2017 | $282,000 | -48.3% | 2,660 | -50.4% | 0.00% | -33.3% |
| Q4 2016 | $545,000 | +1.1% | 5,366 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $539,000 | -16.8% | 5,289 | -2.8% | 0.00% | -25.0% |
| Q2 2016 | $648,000 | +14.3% | 5,441 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $567,000 | +70.8% | 5,305 | +72.5% | 0.00% | +100.0% |
| Q4 2015 | $332,000 | -75.4% | 3,076 | -84.7% | 0.00% | -60.0% |
| Q1 2014 | $1,348,000 | – | 20,057 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |